Before viral clearance, HCV-associated hypolipidemia [4,5] may counter-regulate NAMPT SNP-associated hypercholesteremia to achieve metabolic homeostasis, and the cardiovascular risk in CHC patients carrying a rs61330082 TT genotype may be hidden. This evidence concerns the gene NAMPT and cryohydrocytosis.